Results 21 to 30 of about 16,074 (213)

Diagnostic Power of Bilateral Inferior Petrosal Sinus Sampling with Desmopressin in Paediatric Cushing's Disease

JCRPE, 2022
INTRODUCTION: The aim of this study was to evaluate the diagnostic accuracy of bilateral inferior petrosal sinus sampling (BIPSS) with desmopressin for pediatric Cushing's disease (CD).
Manuel André Virú-loza, Andrea Venegas Quispe   +1 more
doaj   +1 more source

Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus

The FASEB Journal, Volume 36, Issue 11, November 2022., 2022
Abstract Water homeostasis is tightly regulated by the kidneys via the process of urine concentration. During reduced water intake, the antidiuretic hormone arginine vasopressin (AVP) binds to the vasopressin receptor type II (V2R) in the kidney to enhance countercurrent multiplication and medullary osmolality, and increase water reabsorption via ...
Federica Petrillo, Dmitry Chernyakov, Cristina Esteva‐Font, Søren B. Poulsen, Bayram Edemir, Robert A. Fenton   +5 more
wiley   +1 more source

Urinary reabsorption in the rat kidney by anticholinergics

Scientific Reports, 2021
Anticholinergics, therapeutic agents for overactive bladder, are clinically suggested to reduce urine output. We investigated whether this effect is due to bladder or kidney urine reabsorption. Various solutions were injected into the bladder of urethane-
Hideki Oe, Hatsumi Yoshiki, Xinmin Zha, Hisato Kobayashi, Yoshitaka Aoki, Hideaki Ito, Osamu Yokoyama   +6 more
doaj   +1 more source

Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study

Haemophilia, Volume 28, Issue 5, Page 814-821, September 2022., 2022
Abstract Introduction Desmopressin can be used to prevent bleeding in von Willebrand disease (VWD), but the relationship between desmopressin and von Willebrand factor activity (VWF:Act) has yet to be quantified. Aim To quantify the relationship between desmopressin dose, its plasma concentration and the VWF:Act response in type 1 VWD patients ...
Jessica M. Heijdra, Michael E. Cloesmeijer, Nico C.B. de Jager, Frank W.G. Leebeek, Marieke H.J.A. Kruip, Marjon H. Cnossen, Ron A.A. Mathôt, for the OPTI‐CLOT/ To WiN study group and SYMPHONY consortium   +7 more
wiley   +1 more source

Effect of desmopressin on bleeding during endoscopic sinus surgery: A randomized clinical trial

Laryngoscope Investigative Otolaryngology, Volume 7, Issue 4, Page 920-927, August 2022., 2022
Abstract Background This study aimed to evaluate the effect of local nasal desmopressin premedication on blood loss and the quality of surgical field in Functional Endoscopic Sinus Surgery (FESS). Material and methods In a randomized clinical trial, patients referred for FESS to treat their bilateral chronic rhinosinusitis were recruited.
Maliheh Akbarpour, Mir Mohammad Jalali, Maryam Akbari, Soudabeh Haddadi, Ghaffar Fani   +4 more
wiley   +1 more source

Desmopressin testing in von Willebrand disease: Lowering the burden

Research and Practice in Thrombosis and Haemostasis, Volume 6, Issue 6, August 2022., 2022
Abstract Background Individuals with von Willebrand disease (VWD) require desmopressin testing because of interindividual response differences. However, testing is burdensome, while not all patients may need extensive testing. Objectives To provide von Willebrand factor (VWF) cutoffs that predict desmopressin nonresponse and thereby identify ...
Jessica M. Heijdra, Ferdows Atiq, Wala Al Arashi, Quincy Kieboom, Esmee Wuijster, Karina Meijer, Marieke J. H. A. Kruip, Frank W. G. Leebeek, Marjon H. Cnossen, in collaboration with the OPTI‐CLOT Study Group, K. Fijnvandraat, R. A. A. Mathôt, S. Polinder, M. Coppens, R. Y. J. Tamminga, K. Meijer, B. A. P. Laros‐van Gorkom, P. Brons, S. E. M. Schols, F. J. M. van der Meer, H. C. J. Eikenboom, R. E. G. Schutgens, K. Fischer, F. Heubel‐Moenen, L. Nieuwenhuizen, P. Ypma, M. H. E. Driessens, C. M. Zwaan, I. van Vliet, P. W. Collins, R. Liesner, P. Chowdary, D. Keeling, J. Lock, H. C. A. M. Hazendonk, I. van Moort, T. Preijers, N. C. B. de Jager, M. C. H. J. Goedhart, L. H. Bukkems, M. E. Cloesmeijer, A. Janssen   +41 more
wiley   +1 more source

Reciprocal interactions between tumor and endothelial cells: Effects of selective vasopressin V2 receptor peptide agonists [PDF]

, 2014
Recent experimental evidence suggested that the synthetic peptide desmopressin (DDAVP) interferes tumor angiogenesis by inducing the formation of angiostatin.
Alonso, Daniel Fernando, Garona, Juan
core   +1 more source

Desmopressin responsiveness by age in type 1 von Willebrand disease

Research and Practice in Thrombosis and Haemostasis, 2020
Background Patients with type 1 von Willebrand disease (VWD) undergo a desmopressin (DDAVP) responsiveness challenge at diagnosis to assess whether DDAVP reverses their coagulation deficits.
Nicola Goldberg, Rosane Nisenbaum, Hong Song, David Lillicrap, Jerome Teitel, Paula James, Michelle Sholzberg   +6 more
doaj   +1 more source

Vasopressin effectively suppresses male fertility. [PDF]

PLoS ONE, 2013
Arginine vasopressin (VP) is neurohypophysial hormone has been implicated in stimulating contractile activity of the male reproductive tract in the testis. Higher levels of VP decrease sperm count and motility.
Woo-Sung Kwon, Yoo-Jin Park, Yun-Hee Kim, Young-Ah You, In Cheul Kim, Myung-Geol Pang   +5 more
doaj   +1 more source

Preclinical efficacy of [V 4 Q 5 ]dDAVP, a second generation vasopressin analog, on metastatic spread and tumor-associated angiogenesis in colorectal cancer [PDF]

, 2018
Purpose Control of metastatic spread of colorectal cancer (CRC) remains as a major therapeutic challenge. [V 4 Q 5 ]dDAVP is a vasopressin peptide analog with previously reported anticancer activity against carcinoma tumors.
Alonso, Daniel Fernando, Garona, Juan, Gomez, Daniel Eduardo, Pifano, Marina, Ripoll, Giselle Vanina, Segatori, Valeria Inés, Sobol, Natasha Tatiana   +6 more
core   +1 more source